|
SHOC2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.22809606507258E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.33529999677162E-08 |
| Normal-vs-Stage2 |
4.73149999957734E-07 |
| Normal-vs-Stage3 |
2.09570027998041E-10 |
| Normal-vs-Stage4 |
3.91100041241543E-10 |
| Stage1-vs-Stage2 |
4.383200E-01 |
| Stage1-vs-Stage3 |
5.309600E-02 |
| Stage1-vs-Stage4 |
6.735400E-03 |
| Stage2-vs-Stage3 |
5.149800E-01 |
| Stage2-vs-Stage4 |
1.524010E-01 |
| Stage3-vs-Stage4 |
3.647000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.27300425545718E-11 |
| Normal-vs-AfricanAmerican |
1.332080E-02 |
| Normal-vs-Asian |
3.21479999954022E-07 |
| Caucasian-vs-AfricanAmerican |
1.026610E-01 |
| Caucasian-vs-Asian |
9.954000E-01 |
| AfricanAmerican-vs-Asian |
1.450210E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.00810001749608E-09 |
| Normal-vs-Female |
4.32129998451103E-10 |
| Male-vs-Female |
8.109600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.16100000017106E-07 |
| Normal-vs-Age(41-60Yrs) |
1.01589958667603E-10 |
| Normal-vs-Age(61-80Yrs) |
3.54969997840016E-09 |
| Normal-vs-Age(81-100Yrs) |
2.581000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.399600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.824500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.860800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.705200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.079200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.953000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.149900E-02 |
| Classical-VS-Follicular |
8.252800E-01 |
| Classical-VS-Other |
8.258400E-01 |
| Classical-VS-Normal |
5.31010002635668E-09 |
| Tall-VS-Follicular |
1.443770E-01 |
| Tall-VS-Other |
4.293400E-01 |
| Tall-VS-Normal |
1.79950000012141E-07 |
| Follicular-VS-Other |
8.984000E-01 |
| Follicular-VS-Normal |
2.19209999996473E-06 |
| Other-VS-Normal |
1.929710E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.53919987866402E-10 |
| Normal-vs-N1 |
8.36000002557569E-09 |
| N0-vs-N1 |
3.564400E-01 |
|
|
